Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains.

Hernández-Sánchez M, Rodríguez-Vicente AE, González-Gascón Y Marín I, Quijada-Álamo M, Hernández-Sánchez JM, Martín-Izquierdo M, Hernández-Rivas JÁ, Benito R, Hernández-Rivas JM.

Exp Hematol. 2019 Feb 23. pii: S0301-472X(19)30073-6. doi: 10.1016/j.exphem.2019.02.003. [Epub ahead of print]

PMID:
30807786
2.

Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology.

Bastida JM, López-Godino O, Vicente-Sánchez A, Bonanad-Boix S, Xicoy-Cirici B, Hernández-Sánchez JM, Such E, Cervera J, Caballero-Berrocal JC, López-Cadenas F, Arnao-Herráiz M, Rodríguez I, Llopis-Calatayud I, Jiménez MJ, Del Cañizo-Roldán MC, Díez-Campelo M.

Int J Lab Hematol. 2019 Feb;41(1):109-117. doi: 10.1111/ijlh.12933. Epub 2018 Oct 5.

PMID:
30290085
3.

Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders.

Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M, Hernández-Sánchez JM, Riesco S, Bermejo N, González-García H, Rodriguez-Alén A, Aguilar C, Sevivas T, López-Fernández MF, Marneth AE, van der Reijden BA, Morgan NV, Watson SP, Vicente V, Hernández-Rivas JM, Rivera J, González-Porras JR.

Haematologica. 2018 Jan;103(1):148-162. doi: 10.3324/haematol.2017.171132. Epub 2017 Oct 5.

4.

Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia.

Sanchez-Garcia J, Falantes J, Medina Perez A, Hernandez-Mohedo F, Hermosin L, Torres-Sabariego A, Bailen A, Hernandez-Sanchez JM, Solé Rodriguez M, Casaño FJ, Calderon C, Labrador M, Vahí M, Serrano J, Lumbreras E, Hernández-Rivas JM; Grupo Andaluz SMD.

Leuk Lymphoma. 2018 May;59(5):1095-1104. doi: 10.1080/10428194.2017.1366998. Epub 2017 Aug 24.

PMID:
28836866
5.

Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia.

Bastida JM, Benito R, Janusz K, Díez-Campelo M, Hernández-Sánchez JM, Marcellini S, Girós M, Rivera J, Lozano ML, Hortal A, Hernández-Rivas JM, González-Porras JR.

J Thromb Haemost. 2017 Sep;15(9):1859-1866. doi: 10.1111/jth.13777. Epub 2017 Aug 5. Review.

PMID:
28696550
6.

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia.

Quijada-Álamo M, Hernández-Sánchez M, Robledo C, Hernández-Sánchez JM, Benito R, Montaño A, Rodríguez-Vicente AE, Quwaider D, Martín AÁ, García-Álvarez M, Vidal-Manceñido MJ, Ferrer-Garrido G, Delgado-Beltrán MP, Galende J, Rodríguez JN, Martín-Núñez G, Alonso JM, García de Coca A, Queizán JA, Sierra M, Aguilar C, Kohlmann A, Hernández JÁ, González M, Hernández-Rivas JM.

J Hematol Oncol. 2017 Apr 11;10(1):83. doi: 10.1186/s13045-017-0450-y.

7.

Uniparental disomy causes deficiencies of vitamin K-dependent proteins.

Dasi MA, Gonzalez-Conejero R, Izquierdo S, Padilla J, Garcia JL, Garcia-Barberá N, Argilés B, de la Morena-Barrio ME, Hernández-Sánchez JM, Hernández-Rivas JM, Vicente V, Corral J.

J Thromb Haemost. 2016 Dec;14(12):2410-2418. doi: 10.1111/jth.13517. Epub 2016 Nov 19.

8.

FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.

Dubuc AM, Davids MS, Pulluqi M, Pulluqi O, Hoang K, Hernandez-Sánchez JM, Schlich C, Hernández-Rivas JM, Brown JR, Dal Cin P.

Am J Hematol. 2016 Oct;91(10):978-83. doi: 10.1002/ajh.24452. Epub 2016 Jul 22.

9.

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab.

Forero-Castro M, Robledo C, Lumbreras E, Benito R, Hernández-Sánchez JM, Hernández-Sánchez M, García JL, Corchete-Sánchez LA, Tormo M, Barba P, Menárguez J, Ribera J, Grande C, Escoda L, Olivier C, Carrillo E, García de Coca A, Ribera JM, Hernández-Rivas JM.

Br J Haematol. 2016 Feb;172(3):428-38. doi: 10.1111/bjh.13849. Epub 2015 Nov 16.

PMID:
26567765
10.

[Predatory capacity of Macrobrachium tenellum on Aedes aegypti larvae in lab conditions].

Rojas-Sahagún CC, Hernández-Sánchez JM, Vargas-Ceballos MA, Ruiz-González LE, Espinosa-Chaurand LD, Nolasco-Soria H, Vega-Villasante F.

Rev Cubana Med Trop. 2012 Jul-Sep;64(3):315-23. Spanish.

PMID:
23424807
11.

[Family Medicine and university, what do students think?].

Menárguez Puche JF, Tudela de Gea MB, Hernández Sánchez JM, García-Estañ López J.

Aten Primaria. 2010 May;42(5):303-4. doi: 10.1016/j.aprim.2009.07.011. Epub 2009 Oct 28. Spanish. No abstract available.

12.

Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.

Alvarez do Barrio M, González Díez R, Hernández Sánchez JM, Oyonarte Gómez S.

Euro Surveill. 2005 Feb;10(2):20-2.

PMID:
15735311
13.

Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.

Alvarez do Barrio M, González Díez R, Hernández Sánchez JM, Oyonarte Gómez S.

Euro Surveill. 2005 Feb;10(2):11-12. doi: 10.2807/esm.10.02.00521-en.

PMID:
29183492
14.

[A Consensus Conference: clinical indications and risks of fresh frozen plasma].

Rutlant Bañeres M, Arrieta Gallastegui R, Farjas Abadía P, Madoz Resano P, Berbolla García L, Hernández Sánchez JM, Martín Vega C, García Rotlant J.

Rev Sanid Hig Publica (Madr). 1993 Jul-Aug;67(4):249-54. Review. Spanish. No abstract available.

15.

[Infectious diseases and blood transfusion].

Hernández Sánchez JM.

Sangre (Barc). 1993 Jun;38(3):183-5. Review. Spanish. No abstract available.

PMID:
8211544
16.

[Anti-Ge2 in a Ge: -2, -3 patient].

Durán-Suárez JR, Sánchez C, Herrero E, Hernández Sánchez JM.

Sangre (Barc). 1991 Aug;36(4):319-21. Spanish.

PMID:
1776112
17.

[Long term follow-up of non-symptomatic HBsAg carriers].

González A, Vargas V, Hernández-Sánchez JM, Cortina M, Pelegrí D, López-Talavera JC, Genescá J, Jardí R, Esteban R, Guardia J.

An Med Interna. 1991 Jun;8(6):269-72. Spanish.

PMID:
1888839
18.

[Occurrence of antibodies against hepatitis A virus in general population. Comparative study, 1977-1985].

Vargas V, Buti M, Hernández-Sánchez JM, Jardí R, Portell A, Esteban R, Guardia J.

Med Clin (Barc). 1987 Jan 31;88(4):144-6. Spanish. No abstract available.

PMID:
3029524
19.

Mushroom poisoning: therapeutic apheresis or forced diuresis.

Piqueras J, Duran-Suarez JR, Massuet L, Hernandez-Sanchez JM.

Transfusion. 1987 Jan-Feb;27(1):116-7. No abstract available.

PMID:
3810814
20.

[Anti-HTLV-III in hemophilic patients in Barcelona].

Hernández Sánchez JM, Piqueras J, Vila M, Tusell J, Triginer J.

Sangre (Barc). 1985;30(5):857-63. Spanish. No abstract available.

PMID:
3003939
21.

[Causes for the rejection of blood donation offers. 5 years' experience].

Hernández Sánchez JM, Piqueras J, Triginer J.

Sangre (Barc). 1983;28(5):599-606. Spanish. No abstract available.

PMID:
6665696
22.

[Placental transmission of antibodies against the hepatitis B virus].

Pedreira JD, Vargas V, Esteban R, Hernández-Sánchez JM, Guardia J, Bacardí R.

Med Clin (Barc). 1982 Oct 15;79(6):256-7. Spanish. No abstract available.

PMID:
7144311
23.

[Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].

Pedreira JD, Vargas V, Vilaseca J, Esteban R, Hernández-Sánchez JM, Guardia J, Bacardi R.

Med Clin (Barc). 1980 Jun 25;75(2):58-60. Spanish.

PMID:
6249978
24.

[Disease transmission by blood and its derivatives (author's transl)].

Hernández Sánchez JM.

Sangre (Barc). 1980;25(5B):848-55. Spanish. No abstract available.

PMID:
7466561
25.

[Distribution of the antibody against the hepatitis a an antigen (anti-VHA) among the general population (author's transl)].

Vargas V, Hernández-Sánchez JM, Viladoms J, Esteban R, Pedreira JD, Guardia J, Bacardi R.

Med Clin (Barc). 1979 Oct 25;73(7):274-6. Spanish. No abstract available.

PMID:
502632
26.

[HBsAg-negative post-transfusion hepatitis (author's transl)].

Hernández Sánchez JM, Vargas V, Pedreira JD, Esteban R, Ruíz J, Guardia J, Bacardi R.

Sangre (Barc). 1979;24(2):143-7. Spanish. No abstract available.

PMID:
462333
27.

[Enzyme-immunoassay (EIA) in the screening of hepatitis B antigen (HBsAg) in blood donors (author's transl)].

Hernández Sánchez JM, Julia A, Pedreira JD, Esteban R, Guardia J.

Sangre (Barc). 1978;23(1):39-46. Spanish. No abstract available.

PMID:
345496
28.

[Significance of the antigen and the anti-e antibody in patients with surface antigen of hepatitis B virus].

Pedreira JD, Esteban R, Guardia J, Hernández Sánchez JM, Martínez-Vázquez JM, Olmos Miró A, Bacardi R.

Rev Clin Esp. 1977 Jun 30;145(6):445-52. Spanish. No abstract available.

PMID:
302013

Supplemental Content

Loading ...
Support Center